The HYPERION Trial - Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm - Visual Abstract NEJM October 2, 2019 - https://www.nejm.org/doi/full/10.10 Conclusion: Among patients with coma who had been resuscitated from cardiac arrest with nonshockable rhythm, moderate therapeutic hypothermia at 33°C for 24 hours led to a higher percentage of patients who survived with a favorable neurologic outcome at day 90 than was observed with targeted normothermia. Visual Abstract by Tommaso Scquizzato @ https://twitter.com/tscquizzato #HYPERION #Trial #Hypothermia #CardiacArrest #VisualAbstract #EBM #Nonshockable
